Katrin Lamszus - Concepedia

Author

Katrin Lamszus

Universität Hamburg ORCID

Also Known As

K Lamszus, K. Lamszus, K.L. Lamszus, Katrin Lamszus, Kessler, Katrin Lamszus, Lamszus, Katrin, Manfred Westphal

373

Publications

15K

Citations

H-Index

147

Concepts

All Affiliations

Universität Hamburg University Medical Center Hamburg-Eppendorf Heidelberg University German Cancer Research Center University Hospital Heidelberg

About

Katrin Lamszus is an author at Universität Hamburg specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	54	5.7K
2	Health Sciences	7	7	294
3	Engineering	3	3	96
4	Natural Sciences	2	2	69
5	Public Health	1	1	393

Katrin Lamszus

135

Publications

13.2K

Citations

H-Index

Page 1

	Year	Citations
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis Felix Sahm, Daniel Schrimpf, Damian Stichel, The Lancet Oncology ChromatinMendelian DisorderDna Methylation-based ClassificationGrading SystemMedicine	2017	814
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles Franz Ricklefs, Quazim A. Alayo, Harald Krenzlin, Science Advances	2018	595
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma Vidhya M. Ravi, Paulina Will, Jan Kueckelhaus, Cancer Cell	2022	567
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma Ruihuan Chen, Merry Nishimura, Stephanie M. Bumbaca, Cancer Cell Neuro-oncologyTumor HeterogeneityCell BiologyMedicineGlioma	2010	539
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria Hauke S. Günther, Nils Ole Schmidt, Heidi Phillips, Oncogene Neuro-oncologyDevelopmental BiologyPhenotypic CriteriaMedicineAdult Stem Cell	2007	447
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin Albert Lai, Samir Kharbanda, Whitney B. Pope, Journal of Clinical Oncology	2011	438
Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Philip Kunkel, Ulrike Ulbricht, Peter Böhlen, PubMed ImmunologyPathologyHigh-grade GliomasImmunotherapyGlioma	2001	401
TERT Promoter Mutations and Risk of Recurrence in Meningioma Felix Sahm, Daniel Schrimpf, Adriana Olar, JNCI Journal of the National Cancer Institute Prognostic BiomarkersWorld Health OrganizationSomatic VariantTert Promoter MutationsGrading System	2015	393
Hematogenous dissemination of glioblastoma multiforme Carolin Müller, Johannes Holtschmidt, Martina Auer, Science Translational Medicine	2014	324
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth <i>In vivo</i> Tobias Martens, Nils Ole Schmidt, Carmen Eckerich, Clinical Cancer Research	2006	302

Page 1